Altimmune Inc (ALT)
8.455
-1.06
(-11.09%)
USD |
NASDAQ |
Nov 14, 16:00
8.45
0.00 (0.00%)
After-Hours: 20:00
Altimmune Cash and Short Term Investments (Quarterly): 164.91M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 164.91M |
| March 31, 2024 | 182.02M |
| December 31, 2023 | 197.82M |
| September 30, 2023 | 140.78M |
| June 30, 2023 | 159.95M |
| March 31, 2023 | 165.73M |
| December 31, 2022 | 184.88M |
| September 30, 2022 | 201.83M |
| June 30, 2022 | 184.76M |
| March 31, 2022 | 179.95M |
| December 31, 2021 | 190.30M |
| September 30, 2021 | 199.88M |
| June 30, 2021 | 217.83M |
| March 31, 2021 | 226.51M |
| December 31, 2020 | 215.92M |
| September 30, 2020 | 206.78M |
| June 30, 2020 | 80.23M |
| March 31, 2020 | 32.92M |
| December 31, 2019 | 37.24M |
| September 30, 2019 | 39.20M |
| June 30, 2019 | 41.67M |
| March 31, 2019 | 44.30M |
| December 31, 2018 | 33.72M |
| September 30, 2018 | 7.964M |
| June 30, 2018 | 4.171M |
| Date | Value |
|---|---|
| March 31, 2018 | 4.560M |
| December 31, 2017 | 8.770M |
| September 30, 2017 | 17.12M |
| June 30, 2017 | 8.368M |
| March 31, 2017 | 15.78M |
| December 31, 2016 | 2.876M |
| September 30, 2016 | 135.95M |
| June 30, 2016 | 23.16M |
| March 31, 2016 | 14.24M |
| December 31, 2015 | 15.57M |
| September 30, 2015 | 17.39M |
| June 30, 2015 | 18.41M |
| March 31, 2015 | 15.72M |
| December 31, 2014 | 18.64M |
| September 30, 2014 | 19.62M |
| June 30, 2014 | 11.27M |
| March 31, 2014 | 9.535M |
| December 31, 2013 | 10.48M |
| September 30, 2013 | 15.94M |
| June 30, 2013 | 15.79M |
| March 31, 2013 | 12.87M |
| December 31, 2012 | 12.70M |
| September 30, 2012 | 14.73M |
| June 30, 2012 | 11.78M |
| March 31, 2012 | 15.30M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
32.92M
Minimum
Mar 2020
226.51M
Maximum
Mar 2021
166.85M
Average
184.76M
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Eli Lilly and Co | 3.518B |
| Viking Therapeutics Inc | 930.44M |
| Amgen Inc | 9.011B |
| Avid Bioservices Inc | 33.38M |
| NovaBay Pharmaceuticals Inc | 0.776M |